000028 国药一致
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.5336.2623.6639.5369.576
总资产报酬率 ROA (%)0.5852.3511.3513.5473.482
投入资产回报率 ROIC (%)0.8643.4311.9935.3315.305

边际利润分析
销售毛利率 (%)9.95910.68011.09111.99312.154
营业利润率 (%)2.1132.0610.7713.2693.140
息税前利润/营业总收入 (%)2.3072.3051.0963.5483.405
净利润/营业总收入 (%)1.7121.5370.3192.5952.412

收益指标分析
经营活动净收益/利润总额(%)103.824106.230236.50688.96892.314
价值变动净收益/利润总额(%)15.38614.62838.4248.9717.269
营业外收支净额/利润总额(%)0.073-0.2520.3460.2350.216

偿债能力分析
流动比率 (X)1.5561.5401.5151.4941.508
速动比率 (X)1.2291.2291.2161.1661.135
资产负债率 (%)55.39355.95556.35655.90254.372
带息债务/全部投入资本 (%)38.27240.85339.35838.61734.713
股东权益/带息债务 (%)150.805134.875138.425140.732166.172
股东权益/负债合计 (%)69.44867.74265.93065.48669.595
利息保障倍数 (X)11.9849.2483.40413.09213.195

营运能力分析
应收账款周转天数 (天)114.719100.31590.84276.13672.863
存货周转天数 (天)46.53342.62241.90542.88343.126